Gemcitabine(GEM)

DRUG2 trials

Sponsors

Shinshu University, Sun Yat-sen University

Conditions

Nasopharangeal CancerNasopharyngeal Cancinoma (NPC)histologically verified biliary tract cancer (BTCs) with macroscopic complete resection

Phase 2

Adjuvant Chemotherapy with Gemcitabine for Resected Biliary Tract Cancer: A Single-Arm Phase II Study

Active, not recruitingJPRN-UMIN000014018

Shinshu Universityhistologically verified biliary tract cancer (BTCs) with macroscopic complete resection

Start: 2006-10-01Target: 55Updated: 2026-06-29

LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC

RecruitingNCT07325539

Sun Yat-sen UniversityNasopharangeal Cancer, Nasopharyngeal Cancinoma (NPC)

Start: 2026-01-12End: 2030-01-30Target: 55Updated: 2026-05-22

Related Papers

Impact of adjuvant chemotherapy using gemcitabine plus S-1 after surgical resection for advanced biliary cancer.

Journal of Global Oncology2019-10-07